Schwid SR et al. (1997). Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology. 48 [PubMed]
See more from authors:
Schwid SR
·
Petrie MD
·
McDermott MP
·
Tierney DS
·
Mason DH
·
Goodman AD
This website requires cookies and limited processing of your personal data in order to function. By continuing to browse
or otherwise use this site, you are agreeing to this use. See our Privacy policy and
how to cite and terms of use.